TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Stocks in this Quantisnow insightHealth Care
Historical context for TMDX
Across the 29 sessions after earlier TMDX headlines, the stock closed higher 13 times and lower 16 times, with a median move of 2.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TMDX | SPY |
|---|---|---|---|
| Oct 30, 2026 | TransMedics to Present at Upcoming Investor Conferences | -1.7% | -1.8% |
| Oct 23, 2026 | TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026 | -1.8% | -0.5% |
| Oct 7, 2026 | Barclays initiated coverage on TransMedics Group with a new price target | +1.0% | -0.2% |
| Sep 11, 2026 | TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook | -3.4% | +0.9% |
| Sep 1, 2026 | TransMedics to Present at Upcoming September Investor Conferences | -3.1% | -0.7% |
| Aug 5, 2026 | TransMedics Reports Second Quarter 2026 Financial Results | -5.3% | -0.2% |
Keep researching TMDX
- TMDX insider tradesEvery buy and sale reported by TransMedics Group Inc. officers, directors and large holders.
- TMDX earnings historyPast TransMedics Group Inc. earnings releases, newest first.
- TMDX financial statementsRevenue, profit, cash flow and balance sheet from TransMedics Group Inc.'s SEC filings.
Quantisnow market dataNASDAQ
TMDX
TransMedics Group Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2019
Get push alerts for TMDX
Full TMDX profile on Quantisnow Follow TMDX and get a push notification the moment its next story breaks.